Cargando…
Metabolism-based approaches for autosomal dominant polycystic kidney disease
Autosomal Dominant Polycystic Kidney Disease (ADPKD) leads to end stage kidney disease (ESKD) through the development and expansion of multiple cysts throughout the kidney parenchyma. An increase in cyclic adenosine monophosphate (cAMP) plays an important role in generating and maintaining fluid-fil...
Autores principales: | Bakaj, Ivona, Pocai, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980902/ https://www.ncbi.nlm.nih.gov/pubmed/36876046 http://dx.doi.org/10.3389/fmolb.2023.1126055 |
Ejemplares similares
-
Autosomal dominant and autosomal recessive polycystic kidney disease: hypertension and secondary cardiovascular effect in children
por: Lucchetti, L., et al.
Publicado: (2023) -
Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling
por: Zhou, Xia, et al.
Publicado: (2022) -
Shared pathobiology identifies AMPK as a therapeutic target for obesity and autosomal dominant polycystic kidney disease
por: Iliuta, Ioan-Andrei, et al.
Publicado: (2022) -
Activation of the Calcium-Sensing Receptor Corrects the Impaired Mitochondrial Energy Status Observed in Renal Polycystin-1 Knockdown Cells Modeling Autosomal Dominant Polycystic Kidney Disease
por: Di Mise, Annarita, et al.
Publicado: (2018) -
Transcription factor Ap2b regulates the mouse autosomal recessive polycystic kidney disease genes, Pkhd1 and Cys1
por: Wu, Maoqing, et al.
Publicado: (2023)